Bevacizumab and Erlotinib Followed by Cisplatin or Carboplatin and Gemcitabine in Treating Patients With Newly Diagnosed or Recurrent Stage IIIB or Stage IV NSCLC
Clinical trial NCT00354549 · COMPLETED
Trial details
- NCT number
- NCT00354549
- Sponsor
- Swiss Cancer Institute
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-01-01
- Primary completion
- 2009-04-01
- Enrollment
- 104
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.